http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-241688-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53c4a3e9ec4cb735bb5c0bdb92d06f0d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-44 |
| filingDate | 2020-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b1a8c8501b97670862a36bc7220d1f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a577f82c2660412bc2b62a07f5cf92a |
| publicationDate | 2022-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PL-241688-B1 |
| titleOfInvention | A pharmaceutical composition for the implantation of bone tissue, a method for its preparation and its use for the treatment and/or regeneration of bone tissue. |
| abstract | The subject of the invention is a pharmaceutical composition for bone tissue implantation, which contains: 75% powder of gel origin with mineralization potential, 12% MCM-41 mesoporous silica material, 8% MCM-41 mesoporous silica material with 30 mg of active ingredient, 5% ethyl cellulose, g binder. The invention also relates to a method of preparing a composition for implantation of bone tissue and the use of the composition to produce an implant for use in the treatment of bone tissue. |
| priorityDate | 2020-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.